Suppr超能文献

接受经皮冠状动脉介入治疗的老年稳定型缺血性心脏病患者的院内结局及再入院情况。

In-hospital outcomes and readmission in older adults treated with percutaneous coronary intervention for stable ischemic heart disease.

作者信息

Park Dae Yong, Hanna Jonathan M, Kadian Sumeet, Kadian Mannat, Jones W Schuyler, Damluji Abdulla Al, Kochar Ajar, Curtis Jeptha P, Nanna Michael G

机构信息

Department of Medicine, Cook County Health, Chicago, IL, USA.

Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

出版信息

J Geriatr Cardiol. 2022 Sep 28;19(9):631-642. doi: 10.11909/j.issn.1671-5411.2022.09.006.

Abstract

BACKGROUND

Percutaneous coronary intervention (PCI) for stable ischemic heart disease (SIHD) in older adults requires a meticulous assessment of procedural risks and benefits, but contemporary data on outcomes in this population is lacking. Therefore, we examined the risk of near-term readmission, bleeding, and mortality in high-risk cohort of older adults undergoing inpatient PCI for SIHD.

METHODS

We analyzed the National Readmissions Database from 2017 to 2018 to identify index hospitalizations in which PCI was performed for SIHD. Patients were stratified into those ≥ 75 years old (older adults) and those < 75 years old. The primary outcome was 90-day readmission. Secondary outcomes included in-hospital mortality, hospital length of stay (LOS), and total hospital charge.

RESULTS

A total of 74,516 patients underwent inpatient PCI for SIHD, of whom 24,075 were older adults. Older adult patients had higher odds of in-hospital mortality (OR = 2.00, 95% CI: 1.68-2.38), intracranial hemorrhage (OR = 2.03, 95% CI: 1.24-3.34), and gastrointestinal hemorrhage (OR = 1.72, 95% CI: 1.43-2.07) during index hospitalization, with longer LOS and in-hospital charge. Older adults also experienced a higher hazard of 90-day readmission for any cause (HR = 1.61, 95% CI: 1.57-1.66) and cardiovascular causes (HR = 1.84, 95% CI: 1.77-1.91).

CONCLUSION

Older adults undergoing inpatient PCI for SIHD were at increased risk for in-hospital mortality, periprocedural morbidities, higher cost, and readmissions compared with younger adults. Understanding these differences may improve shared decision-making for patients with SIHD being considered for PCI.

摘要

背景

对老年稳定型缺血性心脏病(SIHD)患者进行经皮冠状动脉介入治疗(PCI)需要对手术风险和益处进行细致评估,但目前缺乏该人群治疗结果的相关数据。因此,我们研究了因SIHD接受住院PCI治疗的高危老年人群近期再入院、出血和死亡的风险。

方法

我们分析了2017年至2018年的国家再入院数据库,以确定因SIHD进行PCI治疗的索引住院病例。患者被分为年龄≥75岁(老年人)和年龄<75岁两组。主要结局是90天再入院。次要结局包括住院死亡率、住院时间(LOS)和总住院费用。

结果

共有74516例患者因SIHD接受住院PCI治疗,其中24075例为老年人。老年患者在索引住院期间发生院内死亡(OR = 2.00,95%CI:1.68 - 2.38)、颅内出血(OR = 2.03,95%CI:1.24 - 3.34)和胃肠道出血(OR = 1.72,95%CI:1.43 - 2.07)的几率更高,住院时间更长,住院费用更高。老年人因任何原因(HR = 1.61,95%CI:1.57 - 1.66)和心血管原因(HR = 1.84,95%CI:1.77 - 1.91)发生90天再入院的风险也更高。

结论

与年轻患者相比,因SIHD接受住院PCI治疗的老年人发生院内死亡、围手术期并发症、费用更高和再入院的风险增加。了解这些差异可能会改善考虑接受PCI治疗的SIHD患者的共同决策。

相似文献

1
3
Temporal Trends and Outcomes of Percutaneous Coronary Interventions in Nonagenarians: A National Perspective.
JACC Cardiovasc Interv. 2018 Sep 24;11(18):1872-1882. doi: 10.1016/j.jcin.2018.06.026.
7
10
Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.
J Am Geriatr Soc. 2021 Dec;69(12):3457-3467. doi: 10.1111/jgs.17404. Epub 2021 Aug 7.

引用本文的文献

1
Demographic diversity in platelet function and response to antiplatelet therapy.
Trends Pharmacol Sci. 2025 Jan;46(1):78-93. doi: 10.1016/j.tips.2024.11.005. Epub 2024 Dec 12.
2
Representation of Older Adults in the ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.
JAMA Netw Open. 2024 Jul 1;7(7):e2421547. doi: 10.1001/jamanetworkopen.2024.21547.
3
Chronic Coronary Disease in Older Adults.
Med Clin North Am. 2024 May;108(3):581-594. doi: 10.1016/j.mcna.2023.12.004. Epub 2024 Jan 4.
5
Assessment and Management of Older Adults Undergoing PCI, Part 1: A Expert Panel.
JACC Adv. 2023 Jun;2(4). doi: 10.1016/j.jacadv.2023.100389.
6
The Heterogeneity of Old Age: Healthy Aging in Older Adults Undergoing TAVR.
JACC Cardiovasc Interv. 2023 Jan 23;16(2):189-192. doi: 10.1016/j.jcin.2022.12.008.

本文引用的文献

2
Frailty Predicts Poor Prognosis of Patients After Percutaneous Coronary Intervention: A Meta-Analysis of Cohort Studies.
Front Med (Lausanne). 2021 Aug 19;8:696153. doi: 10.3389/fmed.2021.696153. eCollection 2021.
3
Population Trends in Rates of Percutaneous Coronary Interventions, 2010 to 2017.
JAMA Cardiol. 2021 Oct 1;6(10):1219-1220. doi: 10.1001/jamacardio.2021.2639.
4
External validation of the Hospital Frailty Risk Score in France.
Age Ageing. 2022 Jan 6;51(1). doi: 10.1093/ageing/afab126.
5
Utility of the Hospital Frailty Risk Score Derived From Administrative Data and the Association With Stroke Outcomes.
Stroke. 2021 Aug;52(9):2874-2881. doi: 10.1161/STROKEAHA.120.033648. Epub 2021 Jun 17.
6
An aged immune system drives senescence and ageing of solid organs.
Nature. 2021 Jun;594(7861):100-105. doi: 10.1038/s41586-021-03547-7. Epub 2021 May 12.
9
Comparative Trends in Percutaneous Coronary Intervention in Japan and the United States, 2013 to 2017.
J Am Coll Cardiol. 2020 Sep 15;76(11):1328-1340. doi: 10.1016/j.jacc.2020.07.037.
10
Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy.
JAMA Intern Med. 2020 Nov 1;180(11):1531-1533. doi: 10.1001/jamainternmed.2020.2750.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验